(Context for GHRP synergy mechanisms.) Vahl TP, Christian AF, Grasso LF
Abbreviations T2D: Type 2 diabetes SA: Sleep apnea GLP-1RAs: Glucagon-like peptide-1 receptor agonists LDSC: Linkage disequilibrium score regression MR: Mendelian Randomization IVW: Inverse-variance weighted GWAS: Genome-wide association study eQTL: Expression quantitative trait loci SNP: Single nucleotide polymorphism HbA1c: Glycated hemoglobin A1c OSA: Obstructive sleep apnea CSA: Central sleep apnea AHI: Apneahypopnea index NAFLD: Non-alcoholic fatty liver disease RCT: Randomized controlled trials IV: Instrumental variables References Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al
SLC31A1, solute carrier family 31 member 1
Patients typically notice fewer cravings and smaller portion sizes soon after starting therapy
They will most likely occur when you begin taking the medication or your provider increases your weekly dosage
Understanding their mechanisms can really help us appreciate how they fit into diabetes management and weight loss strategies